Lorenzo Tallarigo - Net Worth and Insider Trading

Lorenzo Tallarigo Net Worth

The estimated net worth of Lorenzo Tallarigo is at least $45 Million dollars as of 2024-11-13. Lorenzo Tallarigo is the President, Internat'l Opers. of Eli Lilly and Co and owns about 55,371 shares of Eli Lilly and Co (LLY) stock worth over $45 Million. Lorenzo Tallarigo is also the Director of Intercept Pharmaceuticals Inc and owns about 0 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $0. Details can be seen in Lorenzo Tallarigo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lorenzo Tallarigo has not made any transactions after 2014-07-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lorenzo Tallarigo

To

Lorenzo Tallarigo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lorenzo Tallarigo owns 2 companies in total, including Intercept Pharmaceuticals Inc (ICPT) , and Eli Lilly and Co (LLY) .

Click here to see the complete history of Lorenzo Tallarigo’s form 4 insider trades.

Insider Ownership Summary of Lorenzo Tallarigo

Ticker Comapny Transaction Date Type of Owner
ICPT Intercept Pharmaceuticals Inc 2014-07-07 director & 10 percent owner
LLY Eli Lilly and Co 2005-03-01 President & Internat'l Opers.

Lorenzo Tallarigo Latest Holdings Summary

Lorenzo Tallarigo currently owns a total of 2 stocks. Among these stocks, Lorenzo Tallarigo owns 55,371 shares of Eli Lilly and Co (LLY) as of March 1, 2005, with a value of $45 Million and a weighting of 100%. Lorenzo Tallarigo also owns 0 shares of Intercept Pharmaceuticals Inc (ICPT) as of July 7, 2014, with a value of $0 and a weighting of 0%.

Latest Holdings of Lorenzo Tallarigo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LLY Eli Lilly and Co 2005-03-01 55,371 815.28 45,142,592
ICPT Intercept Pharmaceuticals Inc 2014-07-07 0 19.00 0

Holding Weightings of Lorenzo Tallarigo


Lorenzo Tallarigo Form 4 Trading Tracker

According to the SEC Form 4 filings, Lorenzo Tallarigo has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 4,000 shares on March 1, 2005, which brought Lorenzo Tallarigo around $222,160.

According to the SEC Form 4 filings, Lorenzo Tallarigo has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 2,000 shares on July 7, 2014, which brought Lorenzo Tallarigo around $486,120.

Insider Trading History of Lorenzo Tallarigo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lorenzo Tallarigo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lorenzo Tallarigo Ownership Network

Ownership Network List of Lorenzo Tallarigo

No Data

Ownership Network Relation of Lorenzo Tallarigo

Insider Network Chart

Lorenzo Tallarigo Owned Company Details

What does Intercept Pharmaceuticals Inc do?

Who are the key executives at Intercept Pharmaceuticals Inc?

Lorenzo Tallarigo is the director & 10 percent owner of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

Lorenzo Tallarigo Mailing Address

Above is the net worth, insider trading, and ownership report for Lorenzo Tallarigo. You might contact Lorenzo Tallarigo via mailing address: 18 Desbrosses Street, New York Ny 10013.